论文部分内容阅读
药物涂层支架被越来越多地应用于冠心病合并糖尿病的患者,近年来,大量的临床试验观察证实,药物涂层支架可以减低冠心病患者经皮冠状动脉介入术后晚期血管狭窄率及血栓形成。综合分析糖尿病患者的特殊病理、生理及经皮冠状动脉介入术后的有效性、安全性及不足,发现药物涂层支架应用于冠心病合并糖尿病患者中,对于一般病变,其短期和中长期临床结果有效、安全,但对于严重狭窄、广泛弥漫病变、左主干病变、复杂病变还是提倡冠状动脉搭桥术治疗。
In recent years, a large number of clinical trials have confirmed that drug-eluting stents can reduce the rate of late stenosis of coronary heart disease patients after percutaneous coronary intervention and Thrombosis. Comprehensive analysis of diabetic patients with special pathology, physiology and percutaneous coronary intervention after the effectiveness, safety and inadequate, found that drug-coated stents in patients with coronary heart disease with diabetes, for general lesions, the short-term and long-term clinical The results are effective and safe, but for severe stenosis, extensive diffuse lesions, left main disease, complicated lesions or to promote coronary artery bypass grafting.